Insmed Inc/ US4576693075 /
2024-05-07 10:00:00 PM | Chg. +0.1300 | Volume | Bid12:30:01 AM | Ask12:30:01 AM | High | Low |
---|---|---|---|---|---|---|
26.0800USD | +0.50% | 1.2 mill. Turnover: 21.45 mill. |
24.5000Bid Size: 2,000 | 27.5500Ask Size: 100 | 26.2200 | 25.6100 |
GlobeNewswire
01-08
NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors
GlobeNewswire
2023-11-07
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire
2023-11-07
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-11-06
Avalyn Strengthens Leadership Team with Key Appointments, including Dr. Craig Conoscenti as SVP, Cli...
GlobeNewswire
2023-08-16
Soleno Therapeutics Announces Appointment of Industry Veteran Matthew Pauls, J.D., M.B.A. to Board o...
GlobeNewswire
2022-01-18
Clarus Therapeutics Appoints Dr. Zhanna Jumadilova as Chief Clinical Development Officer
GlobeNewswire
2021-12-02
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
GlobeNewswire
2021-08-12
Celsion Corporation Reports Second Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-07-01
Tempest Announces Appointment of Christine Pellizzari to its Board of Directors
GlobeNewswire
2021-06-29
Turning Point Therapeutics Appoints Paolo Tombesi as Executive Vice President and Chief Financial Of...
GlobeNewswire
2021-02-16
Strongbridge Biopharma plc Announces Promotion of Richard S. Kollender to President and Chief Financ...
GlobeNewswire
2021-01-20
Imara Announces the Appointment of Kenneth Attie, M.D. as Chief Medical Officer
GlobeNewswire
2020-08-20
Baudax Bio Appoints Arnold Baskies, M.D. and Andrew Drechsler to Board of Directors
GlobeNewswire
2019-05-02
Alder BioPharmaceuticals® Reports First Quarter 2019 Financial and Operating Results